10 Novartis AI and data science leaders
Where AI sits inside Novartis is what these records show best: AI and data science leaders appear in biomedical research, global drug development, medical affairs, US general management and the International business, alongside a Vice President, Head of AI & Platforms. Four list earlier data or AI leadership at Pfizer, GSK, Takeda or Mondelēz International. A call fits a drugmaker deciding where its AI teams should sit.
Professionals to explore
Ahsan Huda, PhD
LinkedInExperience: Vice President, Head of AI & Platforms · Novartis
$2,019 per 30-minute call
Ahsan Huda has been Vice President, Head of AI & Platforms at Novartis since 2026 and was Vice President, Head of Data, Analytics & AI Products there (2025-2026). At Pfizer the titles were Vice President - AI Innovation and Product Development (2024-2025), Head of Data Science and AI/ML Center of Excellence (2022-2024) and Senior Director, Data Science, AI Insights (2020-2022), so building AI products and platforms in pharma is the fit.
Is this you? Claim your profile and get paid for calls.
John Chan
LinkedInExperience: Former Global Head of Digital, Informatics and AI, Biomedical Research · Novartis
$1,683 per 30-minute call
John Chan returned to Novartis as Global Head of Digital, Informatics and AI, Biomedical Research in 2025, having been Executive Director, Head of Informatics and Technology, and Program Innovation there (2010-2017). Takeda titles were Head, ShinrAI Center for Artificial Intelligence and Machine Learning (2022-2025) and Head of Data Strategy, Cell Therapy (2021-2022), and a Visiting Scientist post at the Broad Institute of MIT and Harvard ran 2016-2024.
Is this you? Claim your profile and get paid for calls.
Karim Azer
LinkedInExperience: Global Head of Data & AI · Novartis
$2,019 per 30-minute call
As Global Head of Data & AI at Novartis (since 2024), Karim Azer describes an expanded role developing and applying data and AI in clinical development across all development units. Northeastern University roles include Chair of the Bioengineering IAB (since 2025), part-time lecturer and adjunct professor (since 2024) and Industrial Advisory Board member (since 2019), which suits clinical development AI questions.
Is this you? Claim your profile and get paid for calls.
Marc Díaz-Aguiló
LinkedInExperience: Head of AI and Data Science · Novartis
$1,346 per 30-minute call
Marc Díaz-Aguiló leads AI and data science for Novartis International as Head of AI and Data Science (since 2025). Other Novartis titles are Chief of Innovation, Data, Digital, Bus. Excellence & Customer Engagement (ad interim) (2025), as an executive team member at Novartis Spain, Head of Customer Data & Analytics (2023-2025) and Head of Data & Analytics (2021-2022), a fit for customer engagement and commercial analytics.
Is this you? Claim your profile and get paid for calls.
Rodrigo Kenji Shiramizu
LinkedInExperience: Director of AI & Data Science · Novartis
$606 per 30-minute call
Director of AI & Data Science at Novartis since 2026, leading International AI and data science initiatives across its top 10 countries and the lifecycle of commercial AI and machine learning products. Rodrigo Kenji Shiramizu's earlier Novartis roles were Data Science and Solutions Sr Manager (2025-2026), Reporting and Data Foundation Sr Manager (2020-2025) and FP&A BPA Manager (2018-2020), a path from finance analytics into commercial AI.
Is this you? Claim your profile and get paid for calls.
Sander Timmer, PhD
LinkedInExperience: Head of AI and Data Science - Global Drug Development · Novartis
$1,346 per 30-minute call
Head of AI and Data Science - Global Drug Development at Novartis since 2026, with digital twins, agentic systems and physical AI named as focus areas. Sander Timmer came from GSK, as Global Senior Director, Forward Deployed AI Engineering & Decision Sciences (2025-2026), Global Senior Director of AI/ML & Decision Sciences (2022-2025) and Global Director of Analytics & AI - GSK Vaccines (2019-2022), and lists Microsoft experience.
Is this you? Claim your profile and get paid for calls.
Srayanta Mukherjee
LinkedInExperience: Head of Artificial Intelligence · Novartis Institute For Biomedical Research
$1,010 per 30-minute call
Srayanta Mukherjee has been Head of Artificial Intelligence at the Novartis Institute For Biomedical Research since 2025, described as Head, AI for Research (AI4R). Other roles were Lead Data Scientist (2023-2025) and Principal Data Scientist (2025) at BCG X, and before that Director & Head, MRL&G, Novartis Inst. of Biomed. Research (2023) and Director Data Science at Novartis (2020-2023), a fit for AI in drug research.
Is this you? Claim your profile and get paid for calls.
Stan Tsvirko
LinkedInExperience: Executive Director Functional AI and Process. General Management · Novartis
$673 per 30-minute call
Setting AI strategy for US General Management, including preparation for 30+ future launches across 8 franchises, is the stated remit of Stan Tsvirko's role as Executive Director Functional AI and Process. General Management (since 2026). Earlier Novartis titles include Executive Director - Data, Analytics and AI Products (2025-2026), Executive Director, Head Medical Intelligence and Technology (2022-2025) and Head, Medical Affairs Innovation Lab (2021-2022).
Is this you? Claim your profile and get paid for calls.
Thirupathi Pattipaka
LinkedInExperience: Executive Director, AI and Innovation · Novartis
$673 per 30-minute call
Thirupathi Pattipaka is Executive Director, AI and Innovation at Novartis (since 2026), building an enterprise AI capability from zero with a mandate across Medical Affairs and direct leadership of AI product directors and AI and data engineering staff. Previous Novartis titles include Head, DataScience & AI (2023-2025), Director, Oncology RWE & Data Science (2020-2023) and Associate Director, Clinical Insights (2019-2020).
Is this you? Claim your profile and get paid for calls.
Zahra Heidary, Ph.D.
LinkedInExperience: Head of Data Science, AI and Innovation, Executive Director · Novartis
$673 per 30-minute call
Zahra Heidary has been Head of Data Science, AI and Innovation, Executive Director at Novartis since 2023, and was Director Data Science AI & Innovation there (2020-2022). Zahra was also Head of AI and Data Science, Center of Excellence at Mondelēz International (2022-2023) and Senior Manager Data Scientist (2017-2020) and Associate Director, Data Science (2020-2021) at Otsuka Pharmaceutical Companies (U.S.), useful for comparing data science work at Novartis, Mondelēz International and Otsuka.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Match the person to the part of the business: John Chan or Srayanta Mukherjee for research, Sander Timmer or Karim Azer for clinical development, Thirupathi Pattipaka or Stan Tsvirko for medical affairs and launches, and Marc Díaz-Aguiló or Rodrigo Kenji Shiramizu for commercial AI in international markets. Ahsan Huda, Vice President, Head of AI & Platforms, fits questions on shared AI platforms.
Questions to take into the conversation
- 01How does Novartis decide which AI capabilities are built once as shared platforms and which are built inside research, development or commercial teams?
- 02What does it take to get an AI tool adopted in Novartis clinical development, where validation and regulatory expectations are strict?
- 03How do Novartis AI leaders measure whether an AI product in medical affairs or a drug launch is worth its cost?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.